Similar articles

• [Indications of blood cell and platelet concentrates].

  Chataing B, Revol L. Chataing B, et al. Rev Prat. 1972 Mar 21;22(9):1453-4 passim. Rev Prat. 1972. PMID: 4647335 French. No abstract available.
• [Avoidance of transfusion reactions by the use of largely leukocyte- and thrombocyte-free erythrocyte extracts].

  Marcard E, Spiess HG. Marcard E, et al. Bibl Haematol. 1971;37:194-8. Bibl Haematol. 1971. PMID: 5158186 German. No abstract available.
• Which are the parameters to be controlled in platelet concentrates in order that they may be offered to the medical profession as a standardized product with specific properties?

  [No authors listed] [No authors listed] Vox Sang. 1981 Feb;40(2):115-26. Vox Sang. 1981. PMID: 7233883 No abstract available.
• Platelet transfusion.

  Murphy S. Murphy S. Prog Hemost Thromb. 1976;3:289-310. Prog Hemost Thromb. 1976. PMID: 781733 Review. No abstract available.
• Scientific advances in transfusion.

  O'Riordan JP. O'Riordan JP. J Ir Med Assoc. 1973 Jan 27;66(2):27-36. J Ir Med Assoc. 1973. PMID: 4569809 Review. No abstract available.